Experiment 973819
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | GRAHAM,MA: BISSETT,D: SETANOIANS,A: HAMILTON,T: KERR,DJ: HENRAR,R: KAYE,SB:. (1992). PRECLINICAL AND PHASE I STUDIES WITH RHIZOXIN TO APPLY A PHARMACOKINETICALLY GUIDED DOSE-ESCALATION SCHEME.. 87(7) |
| Amount utilized | |
| Compound isolated | |
| Disease | DOSE WAS ESCALATED BY EXTENDED FACTOR-OF-TWO METHOD. SIDE EFFECTS WERE: WEIGHT LOSS, SLUGGISHNESS, ATAXIA, TRANSIENT HEMATOLOGIC CHANGES AND HEMATURIA. DIARRHEA OCCURRED AT DOSES GREATER THAN 9 MG/SQM. |
| Dose amount | 0.8 MG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | MOUSE |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |